TabletsTablets
Schedule H (Prescription Required)SGLT2 & DPP-4 InhibitorsCode: 2287

Alogliptin 25mg Tablets

Generic Formulation:Alogliptin 25mg Tablets
Pack Size:10's

MRP Under Process

Official PMBI MRP is being updated for catalog code 2287.

Locate Jan Aushadhi Kendra
Clinical InformationReport Error

Clinical Overview

Alogliptin 25mg Tablets is an evidence-based antidiabetic and endocrine pharmaceutical formulation. It acts by regulating metabolic homeostasis, optimizing hormonal signaling pathways, and normalizing blood glucose levels.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 2287.Report inaccuracy

Usage Guidelines

Take orally with a full glass of water at scheduled meal times as prescribed. Adhere to a diabetic diet and routine blood sugar monitoring.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Nausea, gastrointestinal discomfort, mild dizziness, hypoglycemia (when co-administered with secretagogues). Rare/Severe: Severe hypoglycemia and metabolic imbalances.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Prescription medication. Adhere to regular glucose monitoring. Report persistent hypoglycemia or illness to your physician.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered endocrinologist, diabetologist, or qualified physician before initiating, adjusting dosages of, or substituting any antidiabetic or hormonal medication.